drugset / Trial / NCT01463202

Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression

NCT01463202

Phase 4 Completed 184 enrolled Beatrice Chen Society of Family Planning · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

The investigators plan to enroll 184 women who are planning to breastfeed and use DMPA after delivery to find out whether the timing of postpartum administration of DMPA (prior to hospital discharge or 4-6 weeks after delivery) affects the duration or exclusivity of breastfeeding among women who plan to breastfeed their infants.

Timeline

Start
2011-11
Primary completion
2017-02-13
Completion
2017-10-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator medroxyprogesterone acetate Other / unclassified